
|Videos|March 15, 2022
Dr. Bratslavsky discusses emerging research in renal cell carcinoma
Author(s)Urology Times staff
“There are, indeed, numerous paths that we are trying to tackle from different angles,” says Gennady Bratslavsky, MD.
Advertisement
In this video, Gennady Bratslavsky, MD, discusses key research that will be clinically significant in the renal cell carcinoma space. These ideas are associated with a presentation he gave at the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies. Bratslavsky is a Phillip Capozzi M.D. Endowed Professor of Urology, chair of urology, and director of the prostate cancer program at SUNY Upstate Medical University in Syracuse, New York.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Gopa Iyer, MD, highlights data on anti-Nectin-4 ADC for metastatic urothelial carcinoma
2
Ac-225 rosopatamab tetraxetan shows promising activity in Lu-PSMA–pretreated mCRPC
3
FDA updates in urology: June 2026
4
Published VAPOR 2 data evaluate water vapor ablation for localized prostate cancer
5













